Cargando…

The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress—Role of New Drugs, Flozins

Heart failure (HF) is a multifactorial clinical syndrome involving many complex processes. The causes may be related to abnormal heart structure and/or function. Changes in the renin-angiotensin-aldosterone system, the sympathetic nervous system, and the natriuretic peptide system are important in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bodnar, Patryk, Mazurkiewicz, Michalina, Chwalba, Tomasz, Romuk, Ewa, Ciszek-Chwalba, Anna, Jacheć, Wojciech, Wojciechowska, Celina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452694/ https://www.ncbi.nlm.nih.gov/pubmed/37626732 http://dx.doi.org/10.3390/biomedicines11082236

Ejemplares similares

Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2021)

Oxidative Stress Markers and C-Reactive Protein Are Related to Severity of Heart Failure in Patients with Dilated Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2014)

Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology
por: Romuk, Ewa, et al.
Publicado: (2019)

Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure
por: Romuk, Ewa, et al.
Publicado: (2019)

Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
por: Romuk, Ewa, et al.
Publicado: (2020)

Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2022)

Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weight
por: Ghosal, Samit, et al.
Publicado: (2023)

Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy
por: Romuk, Ewa, et al.
Publicado: (2019)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

The concentration of interleukin-33 in heart failure with reduced ejection fraction
por: Anna Segiet, Oliwia, et al.
Publicado: (2019)

β-cell self-destruction and extremely complicated and still unknown etiopathogenesis of type 1 diabetes
por: Chwalba, Artur, et al.
Publicado: (2021)

Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients
por: Wojciechowska, Celina, et al.
Publicado: (2014)

Handheld Capillary Blood Lactate Analyzer as an Accessible and Cost-Effective Prognostic Tool for the Assessment of Death and Heart Failure Occurrence during Long-Term Follow-Up
por: Kubiak, Grzegorz M., et al.
Publicado: (2016)

Nitric Oxide Stroke Volume Index as a New Hemodynamic Prognostic Parameter for Patients with Pulmonary Arterial Hypertension
por: Barańska-Pawełczak, Karolina, et al.
Publicado: (2020)

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors and CKD: Are You a #Flozinator?
por: Krishnan, Anoushka, et al.
Publicado: (2023)

Amantadine in Treatment of Dysthymia—The Pilot Case Series Study
por: Krzystanek, Marek, et al.
Publicado: (2023)

Pregnancy in Patients with Pulmonary Arterial Hypertension in Light of New ESC Guidelines on Pulmonary Hypertension
por: Barańska-Pawełczak, Karolina, et al.
Publicado: (2023)

Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome
por: Kawecki, Damian, et al.
Publicado: (2015)

Effect of Cadmium on Oxidative Stress Indices and Vitamin D Concentrations in Children
por: Chwalba, Artur, et al.
Publicado: (2023)

por: Segiet, Oliwia Anna, et al.
Publicado: (2019)

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
por: Jacheć, Wojciech, et al.
Publicado: (2019)

Updates in pharmacotherapy of heart failure with reduced ejection fraction
por: Espinoza, Clifton, et al.
Publicado: (2021)

Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
por: Jedrzejewska, Agata, et al.
Publicado: (2022)

Heart Failure Pharmacotherapy and Supports in the Elderly - A Short  Review
por: Shakib, Sepehr, et al.
Publicado: (2016)

The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Sodium glucose cotransporter 2 inhibitors: New horizon of the heart failure pharmacotherapy
por: Naito, Ryo, et al.
Publicado: (2021)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Decreased Oxidative Stress in Male Patients with Active Phase Ankylosing Spondylitis Who Underwent Whole-Body Cryotherapy in Closed Cryochamber
por: Stanek, Agata, et al.
Publicado: (2018)

ANP and BNP plasma levels in patients with rheumatic mitral stenosis after percutaneous balloon mitral valvuloplasty
por: Mazurkiewicz, Łukasz, et al.
Publicado: (2017)

A comprehensive review of chronic heart failure pharmacotherapy treatment approaches in African Americans
por: Tillman, Frank, et al.
Publicado: (2019)

Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
por: Paz, Pablo Alejandro, et al.
Publicado: (2021)

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
por: Benko, Jakub, et al.
Publicado: (2022)

Heart failure ejection fraction class conversions: impact of biomarkers, co‐morbidities, and pharmacotherapy
por: Lorenzo, Christian J., et al.
Publicado: (2022)

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021)

Kidney Drug Transporters in Pharmacotherapy
por: Łapczuk-Romańska, Joanna, et al.
Publicado: (2023)

Whole-Body Cryotherapy Decreases the Levels of Inflammatory, Oxidative Stress, and Atherosclerosis Plaque Markers in Male Patients with Active-Phase Ankylosing Spondylitis in the Absence of Classical Cardiovascular Risk Factors
por: Stanek, Agata, et al.
Publicado: (2018)

Decreased Lipid Profile and Oxidative Stress in Healthy Subjects Who Underwent Whole-Body Cryotherapy in Closed Cryochamber with Subsequent Kinesiotherapy
por: Stanek, Agata, et al.
Publicado: (2019)

Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study
por: Sharma, Yogesh, et al.
Publicado: (2022)

Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
por: Grześk, Grzegorz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_172tnqdqs1k2s10mhtdu1av52u